Literature DB >> 15889259

[New methods for the prevention of posterior capsule opacification].

G U Auffarth1, T M Rabsilber, A J Reuland.   

Abstract

Even though tremendous advances have been made especially during the last 10-15 years in terms of surgical techniques and improvement of implant technology, posterior capsule opacification (PCO) still remains a serious long-term complication. New clinical and laboratory studies (especially of autopsy eyes) have improved our understanding of how IOL design and material influence PCO. Sharp edge optic designs of IOLs of various materials have been shown to significantly reduce secondary cataract. The application of pharmacological substances selectively into the capsular bag is now possible due to the development of the PerfectCapsule System for vacuum-sealed capsule irrigation. Major advances in other areas of biotechnology and immunology including gene therapeutic methods offer totally new approaches for the future in the elimination of lens epithelium cells from the capsular bag. This survey gives an update on current and future means and trends to reduce or prevent PCO formation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15889259     DOI: 10.1007/s00347-005-1234-2

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  67 in total

Review 1.  Posterior capsule opacification.

Authors:  D S Clark
Journal:  Curr Opin Ophthalmol       Date:  2000-02       Impact factor: 3.761

2.  Postoperative inflammatory response to phacoemulsification and extracapsular cataract surgery: aqueous flare and cells.

Authors:  M V Pande; D J Spalton; M G Kerr-Muir; J Marshall
Journal:  J Cataract Refract Surg       Date:  1996       Impact factor: 3.351

3.  Relationship between intraocular lens biomaterials and posterior capsule opacification.

Authors:  P G Ursell; D J Spalton; M V Pande; E J Hollick; S Barman; J Boyce; K Tilling
Journal:  J Cataract Refract Surg       Date:  1998-03       Impact factor: 3.351

Review 4.  Intraocular lens implants: a biocompatibility review.

Authors:  A M Beasley; G U Auffarth; A F von Recum
Journal:  J Invest Surg       Date:  1996 Nov-Dec       Impact factor: 2.533

5.  Effect of intraocular sustained release of indomethacin on postoperative inflammation and posterior capsule opacification.

Authors:  O Nishi; K Nishi; T Morita; Y Tada; E Shirasawa; K Sakanishi
Journal:  J Cataract Refract Surg       Date:  1996       Impact factor: 3.351

6.  Prevention of secondary cataract by antimitotic drugs: experimental study.

Authors:  M M Ismail; J L Alió; J M Ruiz Moreno
Journal:  Ophthalmic Res       Date:  1996       Impact factor: 2.892

7.  Inhibition of posterior capsule opacification: the effect of colchicine in a sustained drug delivery system.

Authors:  U F Legler; D J Apple; E I Assia; E C Bluestein; V E Castaneda; S L Mowbray
Journal:  J Cataract Refract Surg       Date:  1993-07       Impact factor: 3.351

8.  Diclofenac sodium and cyclosporin A inhibit human lens epithelial cell proliferation in culture.

Authors:  P Cortina; M J Gómez-Lechón; A Navea; J L Menezo; M C Terencio; M Diaz-Llopis
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-03       Impact factor: 3.117

9.  Prevention of posterior capsule opacification using different intraocular lenses (results of one-year clinical study).

Authors:  Reda Zemaitiene; Vytautas Jasinskas; Valerijus Barzdziukas; Gerd U Auffarth
Journal:  Medicina (Kaunas)       Date:  2004       Impact factor: 2.430

10.  Secondary cataract. An in vivo model for studies on secondary cataract in rabbits.

Authors:  B Lundgren; E Jonsson; W Rolfsen
Journal:  Acta Ophthalmol Suppl       Date:  1992
View more
  2 in total

1.  Prospective, non-randomised, long term clinical evaluation of a foldable hydrophilic single piece intraocular lens: results of the Centerflex FDA study.

Authors:  K A Becker; M Martin; T M Rabsilber; B B Entz; A J Reuland; G U Auffarth
Journal:  Br J Ophthalmol       Date:  2006-05-10       Impact factor: 4.638

2.  Long-term results of sealed capsule irrigation using distilled water to prevent posterior capsule opacification: a prospective clinical randomised trial.

Authors:  Tanja M Rabsilber; Il-Joo Limberger; Andreas J Reuland; Mike P Holzer; Gerd U Auffarth
Journal:  Br J Ophthalmol       Date:  2007-01-03       Impact factor: 4.638

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.